Kamunting Street Capital Management, L.P. Amarin Corp Plcuk Transaction History

Kamunting Street Capital Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$4.26 - $6.5 $129,406 - $197,450	-30,377 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $501,103 - $876,682	-99,623 Reduced 76.63%	30,377 $189,000
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $323,200 - $424,799	80,000 Added 160.0%	130,000 $636,000
Q3 2020 Nov 16, 2020	BUY	$3.64 - $7.76 $91,000 - $194,000	25,000 Added 100.0%	50,000 $211,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $40,000 - $215,300	-10,000 Reduced 28.57%	25,000 $100,000
Q4 2019 Feb 14, 2020	BUY	$13.94 - $24.12 $487,900 - $844,200	35,000 New	35,000 $750,000
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $215,295 - $358,980	-15,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $252,185 - $317,905	15,500 New	15,500 $301,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.